Performix

SST

Serving

1 Capsule(s)

Per container

Form

capsule-unknown

DSLD

268674

Formula hash

f517554ab972

Brand context

Performix

Catalog

products

With avoid flag

products

FDA recalls

history

CAERS

reports

Caution-flaggedObjective label signals

Flagged excipients

0 avoid · 3 caution

FDA recalls

no recall history

CAERS reports

FDA consumer events

Certifications

none recorded

3 excipients carry authority-caution citations. · Every flag below links to the authority's published citation.

Supplement Facts

5 active ingredients

Ingredient	Amount	% DV
Calories otherUNII · 1	10 Calorie(s)	—
Total Fat Fat (unspecified)other	1 Gram(s)	1%
Niacin vitaminUNII · 2679MF687A UL · set3 effects	12 mg	75%
Vitamin B12 vitaminUNII · 8406EY2OQA 3 effects	1000 mcg	41667%
Performix Suspension Super Thermo Complex Blend (Combination)other	1170 mg	—

What this product supports · authorized claims

5 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

↑Normal energy-yielding metabolism
from: Niacin · Vitamin B12
EFSAEU-Reg-432/2012-ID-43 →
↑Normal nervous system function
from: Niacin
EFSAEU-Reg-432/2012-ID-44 →
↑Normal formation of red blood cells + hemoglobin
from: Vitamin B12
EFSAEU-Reg-432/2012-ID-114 →LOINC 789-8
↓Reduction of tiredness and fatigue
from: Niacin
EFSAEU-Reg-432/2012-ID-47 →
↓Normal homocysteine metabolism
from: Vitamin B12
EFSAEU-Reg-432/2012-ID-109 →LOINC 13965-9

Flagged excipients

3 flagged · authority citations

◐ CAUTIONFD&C Blue 1
color
EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.
eur-lex.europa.eu →
◐ CAUTIONFD&C Red 40
color
EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).
eur-lex.europa.eu →leginfo.legislature.ca.gov →
◐ CAUTIONFD&C Yellow 5
color
EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).
eur-lex.europa.eu →ecfr.gov →

FDA CAERS · adverse event context

consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Gelatin · Sucrose · Starch · Talc · Pharmaceutical Glaze · Polyvinylpolypyrrolidone · Calcium Silicate · Maltodextrin · Silicon Dioxide